维普中文期刊产品整合服务
10篇 您的检索式:作者名="Beurskens F"
    题名 作者 年代 出处 被引量
1IL-8 as antibody therapeutic target in inflammatory diseases : reduction of clini- cal activity in palmoplantar pustulosis显示文摘Skov L Beurskens F J Zachariae C O 2008J Immunol2008,181,1:1
2Fc receptor but not complement binding is important in antibody protection against HIV显示文摘Hessell A J Hangartner L Hunter M Havenith C E Beurskens F J Bakker J M Lanigan C M 0,,7158:1
3Binding of submaximal C1q promotes complement-dependent cytotoxicity(CDC)of B ceils opsonized with anti-CD20 ofatumumab(OFA)or rituximab(RTX):considerably higher levels of CDC are induced by OFA than by RTX显示文摘PAWLUCZKOWYCZ A W BEURSKENS F J 2009J Immunol2009,183,1:1
4Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model 显示文摘Villadsen L S Schuurman J Beurskens F 2003Clin Invest2003,112,10:1
5Heliox al- lows for lower minute volume ventilation in an animal model of ventilator - induced lung injury 显示文摘BEURSKENS C J ASLAMI H DE BEER F M 2013PLoS One2013,8,78:1
6CD20 monoclonal antibodies complement activation impacts B-cell depletion by both type I and type显示文摘Beurskens F J Ruuls S R Engelbertsete P J 2008Blood2008,112,:1
7Complement activation on B lymphocytes opsonized with rituximab or ofatumumab produces substantial changes in membrane structure preceding cell lysis显示文摘BEUM P LINDORFER M BEURSKENS F STUKENBERG P LOKHORST H PAWLUCZKOWYCZ A PARREN P VAN DE WINKEL J TAYLOR R 2008J Immunol2008,181,1:1
8Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model显示文摘Villadsen L S Schuurman J Beurskens F 2003J Clin Invest2003,112,10:1
9Comple- ment activation on B lymphocytes opsonizcd with rituximab or ofatumumab produces substantial changes in membrane structurepreceding cell lysis 显示文摘BEUM PV L1NDORFER MA BEURSKENS F 2008J lmmunol2008,181,1:1
10Complement activa- tion on B lymphocytes opsonized with rituximab or ofatumumab pro- duces substantial changes in membrane structure preceding cell lysis 显示文摘Beum P V Lindorfer M A Beurskens F 2008J Immunol2008,181,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费